Clinical Trials Logo

Filter by:
NCT ID: NCT04862273 Active, not recruiting - Clinical trials for Heart Failure With Preserved Ejection Fraction

Native T1 CMR Imaging for Diagnosis of Cardiac Amyloidosis

CMR for CA
Start date: April 1, 2021
Phase:
Study type: Observational

The study aims to test the diagnostic accuracy of native T1 mapping for the diagnosis of cardiac amyloidosis prospectively. The hypothesis is that native T1 mapping with a cut-off value of 1341ms (3 tesla CMR) in older patients with symptomatic heart failure, increased LV wall thickness and elevated cardiac biomarkers is non-inferior to the reference method to diagnose cardiac amyloidosis (CA). As secondary measure, a web-based ATTR probability estimator for the diagnosis of CA will be evaluated.

NCT ID: NCT04865458 Active, not recruiting - Clinical trials for Relapsed or Refractory B-cell Hematologic Malignancies

A Study to Evaluate the Tolerability, Safety, Pharmacokinetics of HEC89736 in Patients With Relapsed or Refractory B-cell Hematologic Malignancies

Start date: April 1, 2021
Phase: Phase 1
Study type: Interventional

Evaluate the safety, pharmacokinetics and efficacy of HEC89736 in patients with Relapsed or Refractory B-cell Hematologic Malignancies

NCT ID: NCT04885595 Active, not recruiting - Lung; Node Clinical Trials

Diagnosis of Peripheral Lung Nodules Using Cryobiopsy

Cryo-Nodule
Start date: April 1, 2021
Phase: N/A
Study type: Interventional

Since the traditional radial endobronchial ultrasound guided biopsy technique of solitary pulmonary nodules using the forceps has several shortcomings, the purpose of this study is to investigate a new biopsy technique using the transbronchial cryobrobe

NCT ID: NCT04894500 Active, not recruiting - Inflammation Clinical Trials

ICIS in Burn Patients Compared to Other Inflammatory Markers

ICARUS
Start date: April 1, 2021
Phase:
Study type: Observational

The current markers of inflammation that govern antibiotic treatment have their significant limitations, especially in patients with burns. According to previously published data, the newly proposed marker of infectious inflammation, the Intensive Care Infection Score (ICIS), appears to be a suitable diagnostic tool in distinguishing between inflammation of infectious and non-infectious origin in these patients. The other advantage is its low price. This study aims to compare ICIS with other used indicators of inflammation in patients with burns both children and adults.

NCT ID: NCT04917744 Active, not recruiting - Ovarian Carcinoma Clinical Trials

Metabolite Levels in Ovarian Cancer Patients Receiving Maintenance PARP Inhibitors

Start date: April 1, 2021
Phase:
Study type: Observational

This study evaluates blood samples and compares levels of metabolites (levels of vitamins, carbohydrates, proteins, etc., that are in the blood), before and after the plasma exchange in patients scheduled to receive immunotherapy for their ovarian cancer. The information gained from this study may help researchers better understand the side effects from each treatment and possibly lessen those side effects for future treatments.

NCT ID: NCT04920656 Active, not recruiting - Breast Cancer Clinical Trials

Universal Genetic Testing Versus Guidelines-Directed Testing for Germline Pathogenic Variants Among Non-Western Patients With Breast Cancer

Start date: April 1, 2021
Phase:
Study type: Observational

The study aims to examinethe pattern and frequency of pathogenic variants among all newly diagnosed breast cancer patients in a genetically distinct population. Additionally, the uptake rate of "cascade family screening" , frequency of pathogenic variants and barriers against testing will be studied.

NCT ID: NCT04999826 Active, not recruiting - Clinical trials for Anatomic Stage III Breast Cancer AJCC v8

Multiscale Omics for the Development of a Cohort Database and Study Platform in Breast Cancer Survivors

Start date: April 1, 2021
Phase:
Study type: Observational

This study gathers information to create a database to improve the ability to diagnose cancer, predict long term health of breast cancer patients, and help develop future treatment products. This study will provide a foundational platform for therapeutic development and intervention studies in the future and may for therapeutic development and intervention studies in the future, and may advance researchers understanding of the contribution gut bacteria to altered circulating estrogens in breast cancer survivors.

NCT ID: NCT05005767 Active, not recruiting - Clinical trials for Chronic Periodontitis

Effect of Frankincense Extract Gel on Non-Surgical Treatment of Chronic Periodontitis

Start date: April 1, 2021
Phase: Phase 2
Study type: Interventional

This study will evaluate the effect of the subgingival application of Frankincense extract gel as an adjunct to scaling and root planning (SRP) in chronic periodontitis.

NCT ID: NCT05009719 Active, not recruiting - Clinical trials for Hematologic Malignancy

Risk-adapted Donor Lymphocyte Infusion After Allo-HSCT in Children With Hematologic Malignancy

Start date: April 1, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

Allo-hsct is potentially curative method of treatment for children and adolescent with hematologic malignancy. However, relapses of disease after allo-hsct occur up to 50% of patients and constitute the main cause of mortality after HSCT. Donor lymphocytes infusion (DLI) is a form of immunotherapy based on developement of reaction "graft versus from leukemia". This study evaluates the safety and efficacy of risk-adapted srtategy of DLI for prophylaxis and prevention posttransplant relapses in children and adolescent with hematologic malignancy.

NCT ID: NCT05041556 Active, not recruiting - Malaria Clinical Trials

Strengthening the Evidence for Policy on the RTS,S/AS01 Malaria Vaccine

MVPE-CC
Start date: April 1, 2021
Phase:
Study type: Observational

The ongoing Malaria Vaccine Pilot Evaluation (MVPE) is being conducted in Ghana, Malawi and Kenya through community and sentinel hospital surveillance systems and a series of household surveys (to measure vaccine coverage). The Malaria Vaccine Pilot Evaluation-Case Control (MVPE-CC) registered here as observational study is embedded within MVPE comprising case-control studies of clinical and mortality outcomes. Each case will require four controls, and caregiver informed consent will be required prior to study activities. These observational case control studies will measure as complementary information to what is being collected through MVPE: 1. Safety among children who received the malaria vaccine, with focus on cerebral malaria, meningitis and severe malaria 2. The impact of the malaria vaccine on all-cause mortality for boys and girls, AND 3. Promote use of case-control approaches by Expanded Programmes on Immunization (EPI) and malaria control programmes.